In prostate cancer, EMP1 is highly expressed in patients with a higher Gleason score, and increasing EMP1 levels significantly increases cancer cell migration, resulting in tumor metastasis, implying that EMP1 may play an important role as a positive regulator of tumor metastasis [8]. Here, EMP1 is linked to prostate carcinoma.